- Advertisement -

PROUD SUPPORTER

Thursday, 1 October 2020

CHARITY TODAY AWARDS

LifeArc backs 15 patient studies into re-purposed therapies to fight coronavirus

- Advertisement -
MEDICAL research charity, LifeArc is providing £10m for clinical trials to find effective therapies for COVID-19. All 15 projects – involving nearly 30 different organisations – were selected for their ability to rapidly start trials in patients and the likelihood of success.

The trials involve medicines that are approved for use in other indications or those in late-stage development with known mechanism of action. This re-purposing approach, where the drug is known to have a target that could be relevant to COVID-19 patients, has a high chance of identifying a treatment in a shorter time than it would take to develop either vaccines or new medicines

Dr Catriona Crombie, Associate Director Technology Transfer, LifeArc, said:

“The quality and quantity of submissions in such a short time frame demonstrated the need for the rapid availability of funding. We are delighted that, as an independently funded charity, LifeArc could respond rapidly and use our resources to identify and support those research projects that had the highest potential to be made available to patients as soon as possible.”

In response to our call to scientists and researchers to submit promising approaches to re-purpose medicines to address COVID-19, LifeArc received more than 130 submissions from organisations across the globe. The charity drew up a short-list of applications using criteria that included the scientific rationale of the approach and ability to start trials within 6-12 months.

An independent, expert Scientific Review Panel assessed the shortlisted applicants and those with the highest chance of delivering improvement to COVID-19 patients were selected for funding.

Organisations involved in the studies come from around the globe, including the UK, China, North America and Japan. The principal investigators are primarily universities, research centres or hospitals.

Professor Stephen Holgate, Chair of the Scientific Review Panel and Professor of Immunopharmacology, University of Southampton, said:

“Finding new treatments for COVID-19 is a hugely important task and this is an important initiative to happen at this crucial time. Responses to this call include so many imaginative and exciting proposals. The panel members did a wonderful job evaluating the applications and I am most grateful to them for the time and effort each of them put into the assessments.”

The submissions covered a range of approaches from new antivirals, immune modulators and anti-thrombotics to treat patients at different stages of infection including prophylaxis, right through to those requiring ventilation.

A number of academic and medical researchers will be collaborating with biotechnology and pharmaceutical companies on the trials. Additional charity and state funders are also providing support.

The LifeArc funding contributes to the national and international response from across the life sciences sector.

Of the 15 proposals selected by the panel, seven have contracts finalised and the details are provided below. The remaining eight will be subject to a further announcement.

Please go to www.lifearc.org/covid to find out more about the funded projects.

- Advertisement -
- Advertisement -

Stay Connected

1,367FansLike
1,834FollowersFollow
30,118FollowersFollow
1,200SubscribersSubscribe

Must Read

Coalition of children’s charities win recognition for work to end physical punishment of children

A campaign by three children's charities which led to Scotland becoming the first country in the UK to end physical punishment of children in...

Charity on a mission to prevent 1,074,000 rabies deaths by 2030

MISSION Rabies, the charity dedicated to eliminating Rabies worldwide, has announced its new campaign "The Final Rabies Generation" that will launch on Monday 28th...
- Advertisement -

Employment News

Creative Land Trust announce the appointment of their first Artist Trustees

MALENE Oddershede Bach and Emmanuel Unaji join Creative Land Trust as Artist Trustees helping build a portfolio of long-term affordable artist studio space. The Creative...

Payzee Mahmod joins Savera UK as Survivor Ambassador

PAYZEE Mahmod, a prominent campaigner against 'honour'-based abuse, female genital mutilation (FGM) and forced marriage has been appointed as a Savera UK Survivor Ambassador.  A...

New Trustees for GroceryAid

GroceryAid has announced three new Trustees have joined the Board in 2020 - Mark McKenzie, Group Sales Director, Nestle UK & Ireland, Dawood Pervez,...

Related News

Hampshire blind veteran grabs first, second and third at annual photography competition

A blind veteran from Fareham in Hampshire placed first, second and third in the ‘Open Print’ category of the Disabled Photographers Society 2020 Annual...

Charity mourns Rodney Powell MBE

Thomas Pocklington Trust has announced that trustee, former Chairman and friend, Rodney Powell MBE, passed away on Friday 25 September. Rodney, Thomas Pocklington’s great-nephew, was...

Jake and Harriet Humphrey named Vice Presidents of CLIC Sargent

JAKE and Harriet Humphrey have been appointed Vice Presidents of CLIC Sargent, the UK's leading charity for children and young people with cancer, after...

£48,000 boost to stroke charity in Memory of G.P. who died of a stroke aged 47

DIFFERENT Strokes, a charity which supports working age and younger stroke survivors, has benefitted from a donation worth £48,380 from Percy's Pals, a fundraising...

Coalition calls on Chancellor to make the £20 a week increase to Universal Credit permanent

OVER 50 signatories representing leading organisations across the United Kingdom have come together in a joint letter to call on the Chancellor to make...
- Advertisement -
X